TITLE

Putting profits to work in CR side of business

PUB. DATE
September 2011
SOURCE
Clinical Trials Administrator;Sep2011, Vol. 9 Issue 9, p103
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses that clinical research groups should pay attention to their profit margins when reviewing proposed budgets sent by sponsors. It highlights that Piedmont Hematology Oncology Associates of Winston-Salem, North Carolina discovered it was operating at a loss when it analyzed profit and loss statements in 2000. Don McCall, research manager for the firm, states that all costs should be taken into consideration before accepting a budget for a clinical trial.
ACCESSION #
65340395

 

Related Articles

  • Direct payments to carers.  // Independent Nurse;1/24/2011, p40 

    The article focuses on the Personal Social Services Survey of Adult Carers in England, 2009-2010, which shows that a total of 8 per cent of carers were in receipt of personal budgets/direct payments managed by the local authority.

  • $2.6M more revenue captured with audits.  // Hospital Case Management;Nov2013, Vol. 21 Issue 11, p157 

    The article reports on the practice at Florida Hospital in Orlando in intentionally reviewing why mistakes in denied claims happen and training the staff for detailed audit of every denial of more than 1,000 dollars as of 2013. Individual meetings with staff members are reportedly done so they...

  • End Cash Flow Forecasting Frustrations with a Reimbursement Reconciliation Process. Beasley, Donna // Clinical Leadership & Management Review;2012 Q1, Vol. 26 Issue 1, p14 

    The article reports on the frustrations of hospital laboratory outreach programs with billing systems and central billing office processes not specifically designed for lab outreach billing. Topics discussed include collection forecast discrepancies, variances in collection rates, budgeting and...

  • Critical Assessment of Belgian Reimbursement Dossiers of Orphan Drugs. Denis, Alain; Mergaert, Lut; Fostier, Christel; Cleemput, Irina; Hulstaert, Frank; Simoens, Steven // PharmacoEconomics;2011, Vol. 29 Issue 10, p883 

    Background: Orphan medicinal products are designed to diagnose or treat rare diseases that are serious, life threatening or chronically debilitating and that affect 50 or fewer people in every 100 000 in the EU. In Belgium, the Drug Reimbursement Committee (DRC) evaluates reimbursement requests...

  • Here are tips on staying compliant with Medicare reimbursement rules.  // Clinical Trials Administrator;May2008, Vol. 6 Issue 5, p55 

    The article offers tips on how to stay compliant with Medicare reimbursement rules for clinical trial bills. Designing a research compliance billing system which classifies what is billable to Medicare and what is not is suggested. One best practice described is doing an analysis from the start...

  • State payer mandates for cancer clinical trials varied widely. Cona, Christen; Harris, Jason; Lawrence, Leah; Southall, Jennifer // Hem/Onc Today;3/25/2010, Vol. 11 Issue 6, p34 

    The article discusses research on state mandates for clinical trial-related medical costs coverage for non-Medicare patients, by P. L. Taylor and colleagues, published in the 2010 issue of the "Journal National Cancer Institute."

  • Meeting the billing challenges inherent with clinical trials. Willenberg, Kelly M. // Oncology Nurse Advisor;Nov/Dec2012, Vol. 3 Issue 6, p11 

    The article presents a continuing education activity based on the article “Meeting the Billing Challenges Inherent with Clinical Trials”.

  • Cancer Clinical Research: Return on Investment in the Era of Value-Based Purchasing. Holcombe, Randall F. // Journal of Oncology Practice;Sep2014, Vol. 10 Issue 5, p327 

    The author reflects on the rate of return for oncologists to offer clinical trials for cancer patients. He states that conducting clinical trials is complex which requires significant investment, however it will improve oncologists' reputation and increases referrals. He discusses value-based...

  • What CR sites need now is Financial Management 101.  // Clinical Trials Administrator;Jul2011, Vol. 9 Issue 7, p73 

    The article suggests that clinical research (CR) sites need to follow best practices of financial management in order to survive difficult economic times. It mentions that Aspen Clinical Research in Orem, Colorado uses quarterly payments initially and then switches to monthly payment cycles....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics